Welcome to Planet Biotechnology Inc.

Planet Biotechnology produced the first plant-made antibody, or “plantibody”, ever tested in a clinical trial. We are focused on discovering, developing and commercializing new antibody-based therapeutic and preventative products through cultivation of genetically modified green plants to meet significant underserved medical needs.
Our Products
CMG2-Fc (PBI-220)
Immunoadhesin for the treatment and prevention of inhalational anthrax.
DPP4-Fc
Immunoadhesin for the treatment of MERS coronavirus infection.
Protein expression and purification services
We offer contract protein expression/purification services and are interested in collaborating on projects involving protein expression in tobacco plants.